Skip to main content

Hillclimb

Traditional eye care requires bulky, clinic based equipment and trained operators, limiting access for patients who live far from specialty centers or have mobility constraints. Delayed or infrequent testing hampers early detection and timely monitoring of progressive eye diseases such as glaucoma, diabetic retinopathy, and age related macular degeneration. Envision Health Technologies provides a portable, virtual reality platform that lets patients complete advanced visual function tests from a clinic, community site, or their own home.

Traction 10/10
San Francisco, United States · HQ
Founded 20254700+ followers
  • Healthcare Technology
  • Digital Health
  • Medical Devices
  • Augmented & Virtual Reality
  • Artificial Intelligence
  • Hardware
  • Data & Analytics
  • Software Only
Updated 9 days ago

Funding

Raised to date

$500KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional eye care requires bulky, clinic-based equipment and trained operators, limiting access for patients who live far from specialty centers or have mobility constraints. Delayed or infrequent testing hampers early detection and timely monitoring of progressive eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration.

Solution

Envision Health Technologies provides a portable, virtual-reality platform that lets patients complete advanced visual function tests from a clinic, community site, or their own home. A lightweight VR headset guides the user through perimetry and other psychophysical assessments while embedded gaze-tracking sensors ensure test reliability. Test data are encrypted and transmitted to a cloud service where proprietary machine-learning models quantify defects, track progression over time, and flag results that warrant clinical review. Clinicians access AI-generated reports and longitudinal trend graphs through a web dashboard or EHR integration, enabling evidence-based treatment adjustments without extra office visits.

Target Audience

Primary users are ophthalmologists, optometrists, and clinical researchers who need frequent, quantitative assessments of visual function in hospital networks and tele-ophthalmology providers seeking scalable screening tools.

Features

  • Stand-alone VR headset with integrated eye-tracking for high-precision perimetry and contrast sensitivity testing
  • Automated fixation monitoring and adaptive stimulus sequencing to maintain test accuracy with minimal operator input
  • Cloud-hosted analytics pipeline that applies deep-learning models to correlate structure-function relationships and predict disease progression risk
  • Web dashboard featuring heat-map visualizations, progression slope calculations, and customizable alert thresholds
  • FHIR-compatible API for seamless export of results into leading electronic health record systems
This profile is AI-generated and may contain inaccuracies.